2016-06-27Zeitschriftenartikel
Safety and immunogenicity of inactivated poliovirus vaccine when given with measles–rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia
Clarke, Ed; Saidu, Yauba; Adetifa, Jane U.; Adigweme, Ikechukwu; Hydara, Mariama Badjie; Moneke-Anyanwoke, Ngozi; Umesi, Ama; Roberts, Elishia; Cham, Pa Modou; Okoye, Michael E.; Brown, Kevin E.; Niedrig, Matthias; Chowdhury, Panchali Roy; Clemens, Ralf; Bandyopadhyay, Ananda S.; Mueller, Jenny; Jeffries, David J.; Kampmann, Beate
Background: The introduction of the inactivated poliovirus vaccine (IPV) represents a crucial step in the polio eradication endgame. This trial examined the safety and immunogenicity of IPV given alongside the measles–rubella ...
